CIK 0001739410
- Emerging growth company
Rallybio Corp
Sign in to watch- Ticker
- RLYB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851083789
- Phone
- +1 203-859-3820
- Business address
- 234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT, 06510
- Former names
- Rallybio Holdings, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,608
- in 1 filing
Net −$9,608. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-24 | Liu Hui Director | Exercise or conversion | +3,562 | $2.38 | $8K | 3,562 |
| 2026-09-24 | Liu Hui Director | Exercise or conversion | +8,482 | $7.60 | $64K | 12,044 |
| 2026-09-24 | Liu Hui Director | Exercise or conversion · Option (Right to Buy) | −3,562 | 0 | ||
| 2026-09-24 | Liu Hui Director | Exercise or conversion · Option (Right to Buy) | −8,482 | $5.60 | $47K | 0 |
| 2025-05-13 | Liu Hui Director | Grant or award · Option (Right to Buy) | +28,500 | 28,500 | ||
| 2025-01-02 | Liu Hui Director | Grant or award · Option (Right to Buy) | +67,857 | $0.70 | $47K | 67,857 |
| 2024-05-15 | Liu Hui Director | Grant or award · Option (Right to Buy) | +16,500 | 16,500 | ||
| 2023-05-17 | Liu Hui Director | Grant or award · Option (Right to Buy) | +15,490 | 15,490 | ||
| 2023-01-03 | Liu Hui Director | Grant or award · Option (Right to Buy) | +10,237 | 10,237 | ||
| 2022-05-24 | Liu Hui Director | Grant or award · Option (Right to Buy) | +2,240 | 2,240 | ||
| 2022-04-04 | Liu Hui Director | Grant or award · Option (Right to Buy) | +26,880 | 26,880 |
Page 1 of 1 · 11 trades